Antiplatelet therapy: in search of the 'magic bullet'
- 1 October 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 2 (10), 775-789
- https://doi.org/10.1038/nrd1198
Abstract
The central importance of platelets in the development of arterial thrombosis and cardiovascular disease is well established. No other single cell type is responsible for as much morbidity and mortality as the platelet and, as a consequence, it represents a major target for therapeutic intervention. The growing awareness of the importance of platelets is reflected in the increasing number of patients receiving antiplatelet therapy, a trend that is likely to continue in the future. There are, however, significant drawbacks with existing therapies, including issues related to limited efficacy and safety. The discovery of a 'magic bullet' that selectively targets pathological thrombus formation without undermining haemostasis remains elusive, although recent progress in unravelling the molecular events regulating thrombosis has provided promising new avenues to solve this long-standing problem.Keywords
This publication has 190 references indexed in Scilit:
- A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart diseaseStatistics in Medicine, 2003
- A PLCγ2‐independent platelet collagen aggregation requiring functional association of GPVI and integrin α2β1FEBS Letters, 2003
- Inflammation in atherosclerosisNature, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- PECAM-1 (CD31) Expression Modulates Bleeding Time in VivoThe American Journal of Pathology, 2000
- Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3′,5′-Monophosphate Kinase IThe Journal of Experimental Medicine, 1999
- The epinephrine-blood platelet connection with special reference to essential hypertensionAmerican Heart Journal, 1991
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990
- Hyperreactive Platelets and Complications of Coronary Artery DiseaseNew England Journal of Medicine, 1987
- Inhibition of Vascular and Platelet Prostaglandin Synthesis by AspirinNew England Journal of Medicine, 1983